Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (211-220 of 420) with videos related to

Pageof 42
Sort By:
Expert Opinion on Biological Therapy|July 28, 2016
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic reviewGiuseppe Di Lorenzo, Sabino De Placido, Martina Pagliuca, et al.
Future Oncology (London, England)|May 31, 2013
Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancerCarlo Buonerba, Gregory R Pond, Guru Sonpavde, et al.
Journal of Cancer Research and Clinical Oncology|August 16, 2022
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancerGiorgio Ivan Russo, Nicolò Musso, Arturo Lo Giudice, et al.
The Prostate|July 2, 2026
Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United StatesLeonardo Quarta, Maximilian Filzmayer, Michele Petix, et al.
International Journal of Molecular Sciences|April 12, 2022
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive ReviewDavide Loizzo, Savio Domenico Pandolfo, Devin Rogers, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Molecular Imaging Diagnosis of Renal Cancer Using <sup>99m</sup>Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel TechniquesOctavian Sabin Tataru, Michele Marchioni, Felice Crocetto, et al.
Andrology|April 14, 2022
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational studyLorenzo Romano, Raffaele Pellegrino, Carmine Sciorio, et al.
Clinical Genitourinary Cancer|May 31, 2024
Thermal Ablation for Small Renal Masses: Identifying Anthropometric Factors for Predicting Perioperative and Oncological OutcomesGennaro Musi, Chiara Vaccaro, Stefano Luzzago, et al.
BJU International|July 2, 2010
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancerGiuseppe Di Lorenzo, Carlo Buonerba, Adriana Faiella, et al.
Critical Reviews in Oncology/Hematology|June 1, 2020
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysisCarlo Buonerba, Matteo Ferro, Pasquale Dolce, et al.
Pageof 42

Showing results (211-220 of 420) with videos related to

Sort By:
Pageof 42
Expert Opinion on Biological Therapy|July 28, 2016
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic reviewGiuseppe Di Lorenzo, Sabino De Placido, Martina Pagliuca, et al.
Future Oncology (London, England)|May 31, 2013
Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancerCarlo Buonerba, Gregory R Pond, Guru Sonpavde, et al.
Journal of Cancer Research and Clinical Oncology|August 16, 2022
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancerGiorgio Ivan Russo, Nicolò Musso, Arturo Lo Giudice, et al.
The Prostate|July 2, 2026
Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United StatesLeonardo Quarta, Maximilian Filzmayer, Michele Petix, et al.
International Journal of Molecular Sciences|April 12, 2022
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive ReviewDavide Loizzo, Savio Domenico Pandolfo, Devin Rogers, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Molecular Imaging Diagnosis of Renal Cancer Using <sup>99m</sup>Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel TechniquesOctavian Sabin Tataru, Michele Marchioni, Felice Crocetto, et al.
Andrology|April 14, 2022
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational studyLorenzo Romano, Raffaele Pellegrino, Carmine Sciorio, et al.
Clinical Genitourinary Cancer|May 31, 2024
Thermal Ablation for Small Renal Masses: Identifying Anthropometric Factors for Predicting Perioperative and Oncological OutcomesGennaro Musi, Chiara Vaccaro, Stefano Luzzago, et al.
BJU International|July 2, 2010
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancerGiuseppe Di Lorenzo, Carlo Buonerba, Adriana Faiella, et al.
Critical Reviews in Oncology/Hematology|June 1, 2020
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysisCarlo Buonerba, Matteo Ferro, Pasquale Dolce, et al.
Pageof 42